Rational Design by Structural Biology of Industrializable, Long-Acting Antihyperglycemic GLP-1 Receptor Agonists
Open accessPublished version of a preprint
The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 (GLP-1) is easily degraded by dipeptidyl peptidase-4 (DPP-4) in the human body, limiting its therapeutic effect on type II diabetes. Therefore, improving GLP-1 receptor agonist (GLP-1RA) stability is a major obstacle for drug development. We analyzed human GLP-1, DPP-4, and GLP-1 receptor structures and designed three GLP-1RAs, which were introduced into fusion protein fragments and changed in the overall conformation. This modification effectively prevented GLP-1RAs from entering the DPP-4 active center without affecting GLP-1RAs’ ability to bind to GLP-1R, the new GLP-1RA hypoglycemic effect lasting for >24 h. Through molecular modeling, molecular dynamics calculation, and simulation, possible tertiary structure models of GLP-1RAs were obtained; molecular docking with DPP-4 and GLP-1R showed access to the fusion protein. The overall conformational change of GLP-1RAs prevented DPP-4 binding, without affecting GLP-1RAs’ affinity to GLP-1R. This study provides important drug design ideas for GLP-1RA development and a new example for application of structural biology-based protein design in drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“GLP-1RAs result from intricate structural modifications to GLP-1, enabling them to not only replicate the pharmacological functions of GLP-1 but also impede its hydrolysis by DPP-4, thereby extending the drug’s half-life.47,48”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A smooth particle mesh Ewald method
Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995) · The Journal of Chemical Physics · doi:10.1063/1.470117 · Cited by 22,514 · cited 1×
“4 nm, the adjacency list was updated every 20 fs, and the PME algorithm was used to calculate of long-range electrostatic interaction [44], where the interpolation order was set to 4 and the tolerance was set to 10−5.”
MethodSaeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792 · cited 2×
“Incidence of diabetes has shown an increasing trend, the 9th edition of the Global Diabetes Atlas(Saeedi et al. 2019) which was released by the International Diabetes Federation (IDF) in 2019, shows that as of 2019, approximately 463 million people aged between 20-79 have diabetes (the vast majority are type II diabet…”
BackgroundInfluentialComparison of multiple Amber force fields and development of improved protein backbone parameters
Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21123 · Cited by 6,914 · cited 1×
“The protein force field used was the AMBER99SB [41] force field.”
MethodI-TASSER: a unified platform for automated protein structure and function prediction
Roy, A., Kucukural, A., & Zhang, Y. (2010) · Nature Protocols · doi:10.1038/nprot.2010.5 · Cited by 6,170
Verification of protein structures: Patterns of nonbonded atomic interactions
Colovos, C., & Yeates, T. O. (1993) · Protein Science · doi:10.1002/pro.5560020916 · Cited by 4,498 · cited 3×
“VERIFY 3D showed that 80.25% of residues had a 3D-1D score ≥ 0.2, and ERRAT scored model3 as 91.78.”
MethodInfluentialP-LINCS: A Parallel Linear Constraint Solver for Molecular Simulation
Hess, B. (2008) · Journal of Chemical Theory and Computation · doi:10.1021/ct700200b · Cited by 3,987
Assessment of protein models with three-dimensional profiles
Lüthy, R., Bowie, J. U., & Eisenberg, D. (1992) · Nature · doi:10.1038/356083a0 · Cited by 3,525 · cited 1×
“VERIFY 3D [38,39] and ERRAT [40] were used to evaluate the predicted models and eliminate unqualified models.”
MethodA Method to Identify Protein Sequences That Fold into a Known Three-Dimensional Structure
Bowie, J. U., Lüthy, R., & Eisenberg, D. (1991) · Science · doi:10.1126/science.1853201 · Cited by 2,851 · cited 1×
“VERIFY 3D [38,39] and ERRAT [40] were used to evaluate the predicted models and eliminate unqualified models.”
MethodThe biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210 · cited 11×
“, and Drucker, D.J. (2014). Pharmacology, physiology, and mechanisms of action of 578 dipeptidyl peptidase-4 inhibitors. Endocr. Rev. 35, 992–1019 [DOI: 10.1210/er.2014-1035]. 579 Pierce, B.G., Wiehe, K., Hwang, H., Kim, B.H., Vreven, T., and Weng, Z. (2014). ZDOCK server: 580 interactive docking prediction of protein…”
BackgroundMethodInfluentialDevelopment of an improved four-site water model for biomolecular simulations: TIP4P-Ew
Horn, H. W., Swope, W. C., Pitera, J. W., Madura, J. D., Dick, T. J., Hura, G. L., & Head-Gordon, T. (2004) · The Journal of Chemical Physics · doi:10.1063/1.1683075 · Cited by 2,121 · cited 1×
“Following this, 12,413 TIP4Pew [42] water molecules, 35 sodium ions, and 35 chloride ions were added to the box, which ensured that the total charge of the system was 0 while the salt concentration of the system reached 140 mM.”
Method
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
“47, 48 By emulating the biological activity of natural GLP-1, GLP-1RAs effectively ful fi ll the role of GLP-1, effectively lowering blood glucose levels without increasing the risk of hypoglycemia and demonstrating favorable safety pro fi les.”
BackgroundSelf-citationRole of oxidative stress in the relationship between periodontitis and systemic diseases
Shang, J., Liu, H., Zheng, Y., & Zhang, Z. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1210449 · Cited by 155
Self-citationAdvances in GLP-1 receptor agonists for pain treatment and their future potential
He, Y., Xu, B., Zhang, M., Chen, D., Wu, S., Gao, J., Liu, Y., Zhang, Z., Kuang, J., & Fang, Q. (2025) · The Journal of Headache and Pain · doi:10.1186/s10194-025-01979-4 · Cited by 46
“GLP-1, an originally identified natu-ral prototype, is synthesized and secreted by intestinal enteroendocrine L-cells and certain neurons within The Journal of Headache and Pain replicating the pharmacological functions [6, 7].”
Self-citationObesity and Exercise: New Insights and Perspectives
James, N. M., & Stanford, K. I. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf017 · Cited by 20
Barać, M., & Roganović, J. (2025) · Biology · doi:10.3390/biology14121650 · Cited by 32
Metadata
- Authors
- Sun, L., Zheng, Z.-M., Shao, C.-S., Zhang, Z.-Y., Li, M.-W., Wang, L., Wang, H., Zhao, G.-H., & Wang, P.
- Affiliations
- University of Science and Technology of China (CN)
- Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences (CAS), Hefei 230031, China
- MOE Key Laboratory for Membraneless Organelles and Cellular Dynamics, National Science Center for Physical Sciences at Microscale, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230022, China
- Chinese Academy of Sciences (CN)
- Corresponding author
- Wang, Peng
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2022-06-13
- Volume
- 15
- Issue
- 6
- Pages
- 740
- ISSN
- 1424-8247 (ISSN-L)
- PMC
- PMC9230455
- OpenAlex
- W4282831524
- Cited by
- 17
- References
- 53
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 2 · 2023: 2
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceuticals (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Major Projects of Science and Technology of Anhui Province (202103a06020003, 2019YFA0904300, 2019YFA0904304, 1804b06020342, 91953101)
- China National Key Research and Development Program (202103a06020003, 2019YFA0904300, 2019YFA0904304, 1804b06020342, 91953101)
- Development Plan of Anhui Province (202103a06020003, 2019YFA0904300, 2019YFA0904304, 1804b06020342, 91953101)
- National Natural Science Foundation of China (202103a06020003, 2019YFA0904300, 2019YFA0904304, 1804b06020342, 91953101)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- GLP-1 receptor agonists, glucagon-like peptide-1, dipeptidyl peptidase IV, type 2 diabetes, antidiabetic drugs, drug stability, fusion protein, conformational change, ligand-receptor interactions, long-acting drugs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.